GlobeStar Therapeutics (GlobeStar Therapeutics) Pretax Margin % : % (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is GlobeStar Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. GlobeStar Therapeutics's Pre-Tax Income for the three months ended in Dec. 2023 was $-0.16 Mil. GlobeStar Therapeutics's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, GlobeStar Therapeutics's pretax margin for the quarter that ended in Dec. 2023 was %.

The historical rank and industry rank for GlobeStar Therapeutics's Pretax Margin % or its related term are showing as below:

GSTC's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -155.98
* Ranked among companies with meaningful Pretax Margin % only.

GlobeStar Therapeutics Pretax Margin % Historical Data

The historical data trend for GlobeStar Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlobeStar Therapeutics Pretax Margin % Chart

GlobeStar Therapeutics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Pretax Margin %

Get a 7-Day Free Trial

GlobeStar Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pretax Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of GlobeStar Therapeutics's Pretax Margin %

For the Biotechnology subindustry, GlobeStar Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlobeStar Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GlobeStar Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where GlobeStar Therapeutics's Pretax Margin % falls into.

GlobeStar Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

GlobeStar Therapeutics's Pretax Margin for the fiscal year that ended in Sep. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	-1.949	/	0
	=	%

GlobeStar Therapeutics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.164	/	0
	=	%

GlobeStar Therapeutics (OTCPK:GSTC) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

GlobeStar Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of GlobeStar Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

GlobeStar Therapeutics (GlobeStar Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlobeStar Therapeutics Corp (OTCPK:GSTC) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

719 Jadewin Avenue, Richland, WA, USA, 99352

Website

https://www.globestarthera.com

GlobeStar Therapeutics Corp is a clinical-stage Pharmaceutical Company introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is focused on developing therapies for people with serious and life-threatening rare disorders.

Executives

James C Katzaroff	director, officer: CEO	719 JADWIN AVE., RICHLAND WA 99352
William J Farley	director	468 ALBERN AVE, OCEANSIDE NY 11572
Robert Chicoski	officer: CFO	145 NEWTON ROAD, HAVERHILL MA 01830
Alex K Blankenship	director, officer: CEO, Pres., Secr., Treas.	14001 WALDEN RD., SUITE 600, MONTGOMERY TX 77356
Brent Atwood	10 percent owner	5000 RIVERSIDE DR STE100E, IRVING TX 75039
Bruce C Badeau	director	770 S. POST OAK LN., STE. 360, HOUSTON TX 77056
Robert W Fryer	director	1520 ENCLAVE, # 1208, HOUSTON TX 77077
Robert Federowicz	director, officer: Interim CEO & Chairman	495 GRAND BLVD., SUITE 206, MIRAMAR BEACH FL 32550